Showing results (1-10 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|July 6, 2022
Epigallocatechin-3-gallate Induced HepG2 Cells Apoptosis through ROSmediated AKT /JNK and p53 Signaling PathwayYutao Guan, Qianlong Wu, Miaomiao Li, et al.Current Cancer Drug Targets|July 6, 2022
Traditional and Novel Computer-Aided Drug Design (CADD) Approaches in the Anticancer Drug Discovery ProcessNidia Del Carmen Quintal Bojórquez, Maira Rubi Segura CamposCurrent Cancer Drug Targets|October 22, 2020
Management of Prostate Cancer with Systemic Therapy: A Prostate Cancer Unit PerspectiveFabio Campodonico, Marco Ennas, Silvia Zanardi, et al.Current Cancer Drug Targets|June 16, 2022
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and MetastasisWei Wang, Dongbo Yuan, Kehua Jiang, et al.Current Cancer Drug Targets|June 17, 2022
Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric CancerRuo-Fei Sun, Na He, Geng-Yuan Zhang, et al.Current Cancer Drug Targets|June 15, 2022
Future Management of Chronic Myeloid Leukemia: From Dose Optimization to New AgentsMassimo Breccia, Emilia Scalzulli, Sara Pepe, et al.Current Cancer Drug Targets|June 3, 2022
The Therapeutic Potential of Urolithin A for Cancer Treatment and PreventionVladimir S RogovskiiCurrent Cancer Drug Targets|November 11, 2010
Current treatment concepts of Philadelphia-negative MPND Wolf, J Rudzki, G GastlCurrent Cancer Drug Targets|January 21, 2011
Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studiesF R Kona, D Buac, A M BurgerCurrent Cancer Drug Targets|January 21, 2011
Clioquinol - a novel copper-dependent and independent proteasome inhibitorA D SchimmerPageof 187